Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on ACC. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel radical-initiated method reduces isomers and simplifies deprotection for scalable API intermediate manufacturing ensuring high purity and supply chain reliability for global pharmaceutical partners.
Patent CN1075718A reveals a novel metal alkoxide route for Taxol synthesis, offering high stereoselectivity and cost reduction in API manufacturing for global supply chains.
Patent CN116375732B reveals high-efficiency non-fullerene acceptor synthesis. Enables cost reduction in electronic chemical manufacturing with scalable processes.
Novel patent CN102775434B offers low-toxicity route for Cabazitaxel intermediate, ensuring supply chain stability and cost efficiency for global pharmaceutical manufacturers seeking reliable partners.
Novel patent method for alpha-cycloalanine offers high yield and purity. Ideal for pharmaceutical intermediate supply chain optimization and cost reduction.
Patent CN101558051A reveals a high-yield docetaxel synthesis using nitro-benzoyl protection, offering significant cost reduction and supply chain reliability for API manufacturers.
Advanced preparation method for Cabazitaxel using safe methylation reagents and ambient temperatures, offering significant cost reduction in API manufacturing.
Patent CN104726504B enables eco-friendly enzymatic production. Offers high purity intermediates for pharmaceutical applications with simplified supply chain.
Novel patent CN102285947B details high-purity Cabazitaxel synthesis. Offers supply chain reliability and cost reduction in pharmaceutical manufacturing.
Patent CN101735167A details a novel synthesis of 6-nitrosaccharin via esterification and diazotization, offering a cleaner alternative to chromium oxidation for herbicide intermediates.
Advanced patent CN104039771B details a safer Cabazitaxel manufacturing route eliminating hazardous pyridine, ensuring high purity and cost reduction in pharmaceutical intermediates production.
Patent CN108892740B reveals a convergent 3+3 synthesis strategy for plant immune elicitors, offering high purity and scalable production for reliable agrochemical intermediate suppliers.
Advanced synthesis of C-13 and C-14 modified taxane derivatives via patent CN107188895B. Offers improved anticancer activity and reduced toxicity for reliable pharmaceutical intermediate supply.
Patent CN108530381B details a solvent-free method for diamine synthesis using saccharin. This offers significant cost reduction and supply chain reliability for API manufacturing.
Novel 10-step route for fondaparinux sodium disaccharide fragment. Reduces steps, uses water solvent, enhances supply chain reliability for pharmaceutical intermediates.
Patent CN114736315B details a novel one-pot synthesis for lentinan core fragments. This route eliminates toxic allyl protection, offering cost reduction in API manufacturing and reliable supply.
Patent CN107011286A details a novel Pd-catalyzed dehydration method for saccharin amides, offering reduced waste and high purity for pharmaceutical intermediate manufacturing.
Patent CN101735117B details a one-step synthesis route offering significant cost reduction and supply chain reliability for high-purity pharmaceutical intermediates.
Patent CN102167686A details a green catalytic oxidation route for 2,2'-dithiodibenzothiazole. This method eliminates salty wastewater, offering significant cost and supply chain advantages for global buyers.
Patent CN113527382B reveals a novel MPLA synthesis route using Nap protection. Achieve higher purity and cost reduction in vaccine adjuvant manufacturing with scalable methods.